EN
HI
Summary
As of 22 Oct, 2026, Aptus Pharma stock price is ₹496. During the trading session, the stock has moved between an intraday low of ₹496.00 and an intraday high of ₹496.00. Over the last 52 weeks, Aptus Pharma has traded between ₹120.25 and ₹496.00.
The stock has recorded a trading volume of 800 shares,. Its Average Traded Price (ATP) is ₹496.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 800 @ ₹496.00.
Aptus Pharma has an upper circuit limit of ₹501.50 and a lower circuit limit of ₹481.90. The total value traded stands at ₹3.97 L, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 400. Aptus Pharma also offers a dividend yield of 0%.
Aptus Pharma Share Price Chart
Aptus Pharma Share Key Metrics
Volume
800.00
Market Cap
843.27 CR
LTQ@LTP
800@496.00
ATP
496
Var Margin
100 %
Circuit Range
481.9-501.5
Delivery %
100 %
Value
3.97 L
ASM/GSM
No
Market Lot
400
Aptus Pharma Resistance and Support
Pivot 488.5
Resistance
First Resistance
494.9
Second Resistance
498.1
Third Resistance
504.5
Support
First Support
485.3
Second Support
478.9
Third Support
475.7
Aptus Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Oct 22 2026 | 496 | 496 | 0.87% | 496 | 496 |
| Wed Oct 21 2026 | 491.7 | 491.7 | 1.99% | 491.7 | 482.1 |
| Mon Oct 19 2026 | 482.1 | 482.1 | 2.00% | 482.1 | 482.1 |
Aptus Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-20 | Half Yearly Results |
| 2026-08-17 | A.G.M. |
| 2026-08-08 | Preferential issue of shares |
| 2026-06-12 | Preferential Issue of shares & Others |
| 2026-04-27 | Audited Results |
| 2026-03-24 | Bonus issue & Others |
| 2025-11-10 | Half Yearly Results |
Aptus Pharma News
Aptus Pharma Ltd - 544529 - Board Meeting Outcome for Outcome Of Board Meeting Held On 20.10.2026 Along With Financial Results For Half Year Ended 30Th September, 2026
Aptus Pharma announced its H1 FY27 results, reporting a revenue of ₹48.92 crore (nearly 2x YoY growth) and a net profit of ₹5.07 crore. The company is actively expanding its national footprint, targeting 46% geographic coverage across India by March 2027.
Oct 20 2026 19:00:36
Aptus Pharma Ltd - 544529 - Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Half Year Ended On September 30, 2026 And Closure Of Trading Window
Aptus Pharma board of directors will meet on 20 Oct 2026 for financial results. The board will also take on record the limited review report.
Oct 15 2026 23:29:52
Aptus Pharma Management
| Name | Position |
|---|---|
| Tejash Maheshchandra Hathi | Managing Director |
| Chetan Shantilal Lalseta | Non Executive Director |
Aptus Pharma Similar Stocks
Krystal Integrated Services Ltd
608.40
3.65 (0.60%)
String Metaverse Ltd.
6.79
-0.10 (1.45%)
Exhicon Events Media Solutions Ltd.
486.00
-5.30 (1.08%)
Maxgrow India Ltd.
199.30
-4.05 (1.99%)
RRP Defense Ltd.
596.60
0.00 (0.00%)
Haldyn Glass Ltd.
142.30
-2.30 (1.59%)
Oricon Enterprises Ltd.
49.00
0.61 (1.26%)
Eco Recycling Ltd.
403.30
0.90 (0.22%)
Aptus Pharma FAQs
The Buying Price of Aptus Pharma share is 496 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aptus Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aptus Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aptus Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aptus Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Aptus Pharma’s valuation compare Sector P/E, P/B which are 56.07 & 1.67 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aptus Pharma is 843.27 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aptus Pharma share price is 496.00 & 120.25. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aptus Pharma belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in APPL
